Lametra Scott, PharmD, CCHP, CEO of Breaking The Sickle Cell Cycle Foundation Inc, discussed the pathophysiology of sickle cell disease (SCD) the dangers of leaving it untreated.
Lametra Scott, PharmD, CCHP, chief executive officer of Breaking The Sickle Cell Cycle Foundation Inc, discussed the pathophysiology of sickle cell disease (SCD) and the dangers of insufficient treatment.
Transcript
What is the pathophysiology of sickle cell disease (SCD) and what are the consequences that may occur if not properly treated?
SCD is very complex in regards to how it affects the body. But in terms of what begins those changes is very simple. It starts with a DNA substitution down at the cellular level, which creates a defective form of hemoglobin. That defective form of hemoglobin does not carry oxygen well, and those red blood cells that contain that defective hemoglobin become very fragile.
So, in that, these cells hemolyze very quickly, which causes anemia and secondary inflammation in the body. That secondary inflammation causes basal occlusion, where those blood cells stick together. Those cells that stick together also form blood clots and those blood clots actually block blood flow. Blocking blood flow is what causes tissue necrosis, organ death, stroke, and even death.
So, that's what's happened along in the hemolysis phase of it. And SCD is also compounded with changing the characteristics of the red blood cells in itself, meaning that those red blood cells in addition to hemolyzing, they also become sticky. They also become a distorted shape. They become hard and rigid. So, these hard rigid sails with a distorted shape that takes on the form of a sickle, hence the name sickle cell, also causes basal occlusion because now that these cells stick to the vasculature, other cells, and each other, they cause basal occlusion.
So, hemolysis and basal occlusion are the primary pathophysiologic concepts associated with SCD that causes all the sequela from the disease. And it is not just one, it's a total body effect that can happen because of sickle cell.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More